V
Valar Labs
Health Tech & Medtech · Palo Alto, United States · Founded 2021
Offers assistance services for cancer treatment through Artificial Intelligence MoreLess
Valar Labs operates at the intersection of artificial intelligence (AI) and oncology, focusing on reducing uncertainty in cancer treatment decisions. The company provides AI-driven diagnostic tests that analyze pathology slides to predict how tumors will respond to various treatments. This helps oncologists and patients make more informed decisions about therapy options. Valar Labs primarily serves oncologists and their patients, operating within the precision oncology market. The business model revolves around the development and sale of diagnostic tests, such as Vesta, the world's first AI test for predicting treatment response in bladder cancer. Revenue is generated through the sale of these diagnostic tests to healthcare providers and institutions. The company recently secured $22 million in Series A funding to advance its AI technology and expand its applications to other types of cancer.
Keywords: AI diagnostics, oncology, precision medicine, pathology slides, tumor analysis, treatment prediction, cancer care, healthcare technology, Series A funding, Vesta test.
Company overview
Valar Labs company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2021
- Headquarters
- Palo Alto, United States
- Employees
- 30
- Open positions
- None listed
- Dealroom signal
- 84.4
Valuation & funding
Valar Labs funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2024 | $22M | $88M | Andreessen Horowitz · Pear Ventures · DCVC | ↗ |
| SEED✓Equity / VC | Apr 2022 | $4M | $16M | Per Båtelson · Dave King · Saharsh Patel · Monishika Gupta | ↗ |
| SEEDEquity / VC | Oct 2021 | $0 | — | Pear Ventures | — |
| SPINOUT✓Other financing | Jan 2021 | — | — | Stanford University | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 30 |
| 2025 | 26 |
| 2024 | 22 |
Growth signals
Valar Labs website traffic
Latest recorded traffic for Valar Labs is 6.8K monthly website visits, up 47.8% over the last three months. Valar Labs's team grew 15.4% over the past year.
Hiring
Open positions at Valar Labs
Current openings linked to this company in Dealroom.
Comparisons
Valar Labs compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Valar Labs's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Valar Labs has talent and traffic
team presence
In the news
Latest news about Valar Labs
Recent press, funding announcements, and product moves mentioning Valar Labs — open to read from the original sources.
Market sentiment
What the market is saying about Valar Labs
An AI-synthesized read of the highest-engagement posts about Valar Labs on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Valar Labs’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.